BIOMARKER:

EGFR T790M

A1 | Sensitive

A2 | Sensitive

B | Sensitive

C1 | Sensitive

C2 | Sensitive

C3 | Sensitive

C4 | Sensitive

D | Sensitive

A1 | Resistant

A2 | Resistant

B | Resistant

C1 | Resistant

C2 | Resistant

C3 | Resistant

C4 | Resistant

D | Resistant

Non Small Cell Lung Cancer

Lung Adenocarcinoma

Lung Non-Squamous Non-Small Cell Cancer

Lung Cancer

Small Cell Lung Cancer

Gallbladder Cancer

Pancreatic Cancer

osimertinib

EGFR T790M|Non Small Cell Lung Cancer|osimertinib

EGFR T790M|Lung Adenocarcinoma|osimertinib

EGFR T790M|Lung Non-Squamous Non-Small Cell Cancer|osimertinib

EGFR T790M|Small Cell Lung Cancer|osimertinib

EGFR T790M|Lung Cancer|osimertinib

gefitinib

EGFR T790M|Non Small Cell Lung Cancer|gefitinib

EGFR T790M|Lung Adenocarcinoma|gefitinib

erlotinib + ramucirumab

EGFR T790M|Non Small Cell Lung Cancer|erlotinib + ramucirumab

bevacizumab

EGFR T790M|Non Small Cell Lung Cancer|bevacizumab

erlotinib

EGFR T790M|Non Small Cell Lung Cancer|erlotinib

EGFR T790M|Lung Adenocarcinoma|erlotinib

EGFR T790M|Gallbladder Cancer|erlotinib

EGFR T790M|Pancreatic Cancer|erlotinib

osimertinib + ramucirumab

EGFR T790M|Non Small Cell Lung Cancer|osimertinib + ramucirumab

EGFR T790M|Lung Adenocarcinoma|osimertinib + ramucirumab

SH-1028

EGFR T790M|Non Small Cell Lung Cancer|SH-1028

osimertinib + anlotinib

EGFR T790M|Non Small Cell Lung Cancer|osimertinib + anlotinib

AUY922

EGFR T790M|Non Small Cell Lung Cancer|AUY922

bevacizumab + osimertinib

EGFR T790M|Non Small Cell Lung Cancer|bevacizumab + osimertinib

EGFR T790M|Lung Adenocarcinoma|bevacizumab + osimertinib

WZ4002

EGFR T790M|Non Small Cell Lung Cancer|WZ4002

APL-103

EGFR T790M|Non Small Cell Lung Cancer|APL-103

lazertinib

EGFR T790M|Non Small Cell Lung Cancer|lazertinib

aumolertinib

EGFR T790M|Non Small Cell Lung Cancer|aumolertinib

afatinib

EGFR T790M|Non Small Cell Lung Cancer|afatinib

EGFR T790M|Lung Adenocarcinoma|afatinib

rociletinib

EGFR T790M|Non Small Cell Lung Cancer|rociletinib

ASP8273

EGFR T790M|Non Small Cell Lung Cancer|ASP8273

ASK120067

EGFR T790M|Non Small Cell Lung Cancer|ASK120067

olmutinib

EGFR T790M|Non Small Cell Lung Cancer|olmutinib

osimertinib + ABT 263

EGFR T790M|Non Small Cell Lung Cancer|osimertinib + ABT 263

amivantamab-vmjw

EGFR T790M|Non Small Cell Lung Cancer|amivantamab-vmjw

anlotinib

EGFR T790M|Non Small Cell Lung Cancer|anlotinib

furmonertinib

EGFR T790M|Non Small Cell Lung Cancer|furmonertinib

abivertinib

EGFR T790M|Non Small Cell Lung Cancer|abivertinib

befotertinib

EGFR T790M|Non Small Cell Lung Cancer|befotertinib

imatinib

EGFR T790M|Non Small Cell Lung Cancer|imatinib

afatinib + ruxolitinib

EGFR T790M|Non Small Cell Lung Cancer|afatinib + ruxolitinib

cetuximab + brigatinib

EGFR T790M|Non Small Cell Lung Cancer|cetuximab + brigatinib

osimertinib + APG-1252

EGFR T790M|Non Small Cell Lung Cancer|osimertinib + APG-1252

brigatinib

EGFR T790M|Lung Adenocarcinoma|brigatinib

BPI-7711

EGFR T790M|Non Small Cell Lung Cancer|BPI-7711

BBT-176

EGFR T790M|Non Small Cell Lung Cancer|BBT-176

BPI-15086

EGFR T790M|Non Small Cell Lung Cancer|BPI-15086

pembrolizumab

EGFR T790M|Non Small Cell Lung Cancer|pembrolizumab

neratinib + PF-05212384

EGFR T790M|Non Small Cell Lung Cancer|neratinib + PF-05212384

neratinib

EGFR T790M|Non Small Cell Lung Cancer|neratinib

Compound 6a

EGFR T790M|Non Small Cell Lung Cancer|Compound 6a

EGFR T790M|Non Small Cell Lung Cancer|

APG-1252

EGFR T790M|Non Small Cell Lung Cancer|APG-1252

osimertinib + DC101

EGFR T790M|Non Small Cell Lung Cancer|osimertinib + DC101

gefitinib + nirogacestat

EGFR T790M|Lung Adenocarcinoma|gefitinib + nirogacestat

bevacizumab + erlotinib

EGFR T790M|Non Small Cell Lung Cancer|bevacizumab + erlotinib

bevacizumab + gefitinib

EGFR T790M|Non Small Cell Lung Cancer|bevacizumab + gefitinib

MTI-31

EGFR T790M|Non Small Cell Lung Cancer|MTI-31

BMS-722782

EGFR T790M|Lung Cancer|BMS-722782

EGFR inhibitor

EGFR T790M|Non Small Cell Lung Cancer|EGFR inhibitor

EGFR T790M|Lung Adenocarcinoma|EGFR inhibitor

EGFR T790M|Lung Cancer|EGFR inhibitor

ABCP

EGFR T790M|Lung Non-Squamous Non-Small Cell Cancer|ABCP

PD-L1 inhibitor

EGFR T790M|Lung Non-Squamous Non-Small Cell Cancer|PD-L1 inhibitor

Tyrosine kinase inhibitor

EGFR T790M|Non Small Cell Lung Cancer|Tyrosine kinase inhibitor

EGFR T790M|Lung Adenocarcinoma|Tyrosine kinase inhibitor

PD1 inhibitor

EGFR T790M|Non Small Cell Lung Cancer|PD1 inhibitor